\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes Advanced Digital SkillsA number of Q&As are now available for the currently open calls for proposals in advanced digital skills under the DIGITAL Europe Programme:
Another source of information is the recording of the presentation from the Commission during the Info day and Matchmaking event “Partner for DIGITAL Skills” (1 December 2022).
We remind you that the deadline for submitting your proposal is 22 February 2022 (17:00 Brussels time). Do not wait until the last minute to submit the proposal. You can already open the submission service on the EU Funding and Tendering Portal and start drafting your proposal. This draft can be saved in the system and re-opened at any time.
If you are still looking for partners to complete the consortium, you can also have a look at the Digital Skills and Jobs platform, register for the Community and join the Partner for DIGITAL Skills Networking group.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
